The cytochrome P450 oxidoreductase deficiency, breast cancer, bilirubin metabolic disorder, hepatocellular carcinoma, and Gilbert syndrome have the highest correlation with the abnormal expression of UGT2B7. Here, UGT2B7 is linked to breast carcinoma.